Gastrointestinal Imaging

Should You Order CTA for Suspected Nonvariceal UGIB When Endoscopy Isn’t Performed First?

·
Should You Order CTA for Suspected Nonvariceal UGIB When Endoscopy Isn't Performed First?

It’s 2 a.m. in the emergency department, and you’re managing a 68-year-old male with sudden-onset hematemesis and melena. He is hypotensive and tachycardic, requiring resuscitation. While gastroenterology has been consulted, endoscopy is not immediately available, and you need to locate the source of a suspected nonvariceal upper gastrointestinal (GI) bleed to guide the next, potentially life-saving, intervention. This is a critical juncture where initial imaging can define the subsequent therapeutic pathway. For this specific scenario—an adult with suspected nonvariceal upper GI bleeding where endoscopy has not been performed—the American College of Radiology (ACR) Appropriateness Criteria rate CTA abdomen and pelvis without and with IV contrast as Usually Appropriate. This article details the clinical workflow for this exact presentation.

Who Fits This Clinical Scenario?

This guidance is for a specific patient population: an adult presenting with clinical signs of acute upper gastrointestinal bleeding (UGIB), such as hematemesis, coffee-ground emesis, or melena, where a nonvariceal source is suspected. The crucial qualifier is that an upper endoscopy has not yet been performed, either due to patient instability, resource availability, or other logistical delays. The patient is often hemodynamically unstable or has signs of ongoing, significant bleeding that necessitates rapid localization of the source.

This workflow is distinct from several related clinical situations. It does not apply if:

  • Endoscopy has already been performed: If an endoscopy confirmed a bleeding source but treatment was not possible, or if the endoscopy was negative, the imaging strategy changes. Those are covered in separate ACR variants.
  • A variceal bleed is strongly suspected: In a patient with known cirrhosis and portal hypertension, the pre-test probability of variceal bleeding is high, and the management pathway is different, prioritizing endoscopic intervention.
  • The bleed is postsurgical or traumatic: These cases have a unique differential (e.g., suture line dehiscence, pseudoaneurysm) and are addressed in a separate ACR scenario, especially if endoscopy is contraindicated.

What Diagnoses Are You Working Up in This Scenario?

When ordering imaging for a suspected nonvariceal UGIB, you are primarily trying to localize an active bleed and identify the underlying cause. The differential diagnosis guides the imaging protocol and interpretation.

Peptic Ulcer Disease (PUD): This is the most common cause of nonvariceal UGIB. Ulcers, particularly in the posterior duodenal bulb, can erode into adjacent arteries like the gastroduodenal artery, causing massive hemorrhage. CTA is highly effective at identifying the contrast blush from an actively bleeding ulcer.

Dieulafoy’s Lesion: This is a less common but important cause of severe, often intermittent, bleeding. It consists of an abnormally large, tortuous arteriole in the submucosa that erodes through the overlying epithelium without a primary ulcer. Because of its small size, it can be difficult to spot on endoscopy, but the active arterial bleeding is readily detectable on CTA.

Aortoenteric Fistula: A rare but catastrophic diagnosis, an aortoenteric fistula is an abnormal connection between the aorta and the GI tract, most often the duodenum. It is a critical consideration in patients with a history of aortic aneurysm or aortic graft surgery. CTA is the diagnostic test of choice, looking for signs like periaortic gas, fluid, or direct extravasation of contrast from the aorta into the bowel.

Upper GI Malignancy: Tumors of the stomach, duodenum, or esophagus can ulcerate and bleed. CTA can not only identify active bleeding from a tumor but also delineate the extent of the mass and potential metastatic disease, which is crucial for treatment planning.

Why Is CTA Abdomen and Pelvis Without and With IV Contrast the Recommended Study?

The ACR designates multiphase CTA abdomen and pelvis without and with IV contrast as Usually Appropriate because it directly addresses the primary clinical question: where is the bleeding, and what is the cause? The multiphase technique is key to its high diagnostic yield.

The protocol involves three distinct scans:

  1. Non-contrast phase: This initial scan helps identify high-density material that could be confused with contrast extravasation, such as surgical clips, calcified plaque, or intramural hematoma. It provides a baseline to confidently identify active bleeding on subsequent phases.
  2. Arterial phase: Timed for peak arterial enhancement, this is the most critical phase for detecting active bleeding. A focus of high-density contrast within the bowel lumen that was not present on the non-contrast images is the hallmark of active extravasation.
  3. Portal venous phase: This phase helps characterize the bleeding source (e.g., a tumor that enhances avidly) and can detect venous bleeding, though less common. It also provides a comprehensive evaluation of the abdominal and pelvic organs for other potential pathologies.

    4. end

    In contrast, other imaging modalities are rated lower for this initial workup. A standard, single-phase CT abdomen and pelvis with IV contrast is rated Usually not appropriate because it may miss the brief, transient blush of arterial extravasation. The timing has to be precise, which the multiphase protocol ensures. Similarly, a Tagged Red Blood Cell (RBC) scan is also Usually not appropriate for this initial, acute scenario. While sensitive for detecting slow or intermittent bleeding, it provides poor anatomic localization, making it unsuitable for guiding emergent interventions like angiography or surgery.

    The recommended CTA protocol carries a relative radiation level of ☢☢☢☢ (10-30 mSv). While significant, this radiation exposure is justified in the setting of a life-threatening hemorrhage where rapid and accurate diagnosis is paramount to guiding therapy.

    What’s Next After CTA Abdomen and Pelvis Without and With IV Contrast? Downstream Workflow

    The results of the CTA will directly guide your next steps in managing the patient. The primary goal is to use the imaging findings to triage the patient to the most effective therapy.

    • If the CTA is positive for active bleeding: A finding of contrast extravasation is a clear target for intervention. The patient should be immediately evaluated by interventional radiology for transcatheter arterial embolization. The CTA serves as a precise roadmap, allowing the interventional radiologist to select the appropriate vessel for catheterization and treatment, saving valuable time and reducing procedural complexity. In some cases, a positive CTA may guide an emergent surgical intervention.
    • If the CTA is negative for active bleeding: A negative CTA in a hemodynamically stabilizing patient suggests the bleeding may have temporarily or permanently stopped. The patient should proceed to upper endoscopy once stable and it becomes available. The CTA may still provide value by identifying a potential non-bleeding source, such as a tumor or a large ulcer with a visible vessel.
    • If the CTA is negative but the patient remains unstable: This is a challenging situation. It may indicate a very slow or intermittent bleed below the detection threshold of CTA. Repeat CTA, provocative angiography, or an urgent push for endoscopy may be considered, depending on the clinical context and local expertise. This may also prompt consideration of a lower GI bleeding source if the clinical picture is ambiguous.

    Pitfalls to Avoid (and When to Get Help)

    In the high-stakes environment of an acute GI bleed, several pitfalls can compromise the diagnostic process. Be mindful to avoid ordering a standard single-phase CT, as this is a common error that significantly reduces sensitivity for active bleeding. Ensure the order explicitly requests a multiphase “GI Bleed” or “Mesenteric Ischemia” protocol. Patient motion can severely degrade image quality; ensure the patient is stable enough for the scan and communicate the need for breath-holding to the technologist. Finally, poor communication with the radiology team can lead to a missed diagnosis; always provide a clear clinical history of suspected UGIB so the radiologist knows precisely what to look for. If the CTA is positive in an unstable patient, this is a critical result that requires immediate escalation to interventional radiology and/or a surgical service.

    Related ACR Topics and Tools

    This article covers one specific scenario in depth. For a broader view of all clinical variants or to explore related tools, the following resources are available:

    Frequently Asked Questions

    Why not just wait for endoscopy instead of ordering a CTA?

    In a hemodynamically unstable patient or when endoscopy is not immediately available, CTA provides rapid localization of the bleeding source. This information is critical for triaging the patient to the correct intervention, such as angiography for embolization, which can be life-saving. It acts as a bridge to definitive therapy when endoscopy is delayed.

    What is the minimum bleeding rate that CTA can detect?

    Multiphase CTA can generally detect active arterial bleeding at rates as low as 0.3 to 0.5 mL/minute. This is significantly more sensitive than older methods like conventional angiography and makes it a powerful tool for identifying even relatively small but clinically significant bleeds.

    Is CTA still useful if the patient is hemodynamically stable?

    Yes, although endoscopy is often the first choice in stable patients, CTA can be valuable if there is a concern for specific high-risk lesions like an aortoenteric fistula, where endoscopy carries a risk of catastrophic hemorrhage. It can also be used if a patient has had multiple negative endoscopies for intermittent bleeding.

    What if my patient has renal insufficiency and I’m concerned about contrast-induced nephropathy?

    This is a risk-benefit calculation. In a patient with life-threatening hemorrhage, the benefit of locating the bleed with a CTA almost always outweighs the risk of contrast-induced nephropathy. Pre-scan hydration and communication with the radiology department are essential. The risk of mortality from an uncontrolled bleed is far greater than the risk of acute kidney injury.

    Why is the non-contrast phase of the CTA so important?

    The non-contrast phase provides a baseline map of high-density structures in the abdomen. Without it, things like surgical clips, dense stool, or intramural hematoma could be mistaken for active contrast extravasation on the arterial or venous phases, leading to a false-positive diagnosis. It is essential for accurate interpretation.

    Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026